Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis

研究成果: Article同行評審

1 引文 斯高帕斯(Scopus)

摘要

ABSTRACT: Dual-time-point 18 F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indicated a benign hemangioma rather than a metastasis.

原文English
頁(從 - 到)332-334
頁數3
期刊Clinical Nuclear Medicine
48
發行號4
DOIs
出版狀態Published - 2023 4月 1

All Science Journal Classification (ASJC) codes

  • 放射學、核子醫學和影像學

指紋

深入研究「Dual-Time-Point 18 F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis」主題。共同形成了獨特的指紋。

引用此